Location History:
- Nanjing, CN (2019)
- Jiangsu Province, CN (2021)
- Jiangsu, CN (2022)
Company Filing History:
2 out of 2 
2 out of 2 
1 out of 1 Years Active: 2019-2022
Title: Mei Su: Innovator in Pharmaceutical Chemistry
Introduction
Mei Su is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 3 patents, her work focuses on innovative solutions for treating various diseases.
Latest Patents
One of Mei Su's latest patents is titled "Modulator of indoleamine 2,3-dioxygenase, preparation method and use thereof." This invention relates to a modulator of 1,2,5-oxadiazole indoleamine-(2,3)-dioxygenase, including compounds of specific formulas and their use in preparing drugs for treating cancers, neurodegenerative diseases, eye diseases, mental disorders, depression, anxiety disorders, Alzheimer's diseases, and autoimmune diseases.
Another significant patent is "Pyrrole sulfonyl derivative, preparation method and medical use thereof." This invention introduces a new pyrrole sulfonyl derivative, detailing its preparation method and medical applications. The derivative serves as a therapeutic agent, particularly as a gastric acid secretion inhibitor and potassium-competitive acid blocker (P-CAB).
Career Highlights
Mei Su has worked with notable companies in the pharmaceutical industry, including Nanjing Carephar Shenghui Pharmaceutical Co., Ltd. and Jiangsu Carephar Pharmaceutical Co., Ltd. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Mei Su has collaborated with several professionals in her field, including Yinlin Qin and Tao Chen. These partnerships have enhanced her research and development efforts, leading to impactful inventions.
Conclusion
Mei Su's contributions to pharmaceutical chemistry through her innovative patents demonstrate her commitment to advancing medical science. Her work continues to influence the development of new therapeutic agents for various health conditions.